Seqirus UK Limited
General
Jobs•0
Shortlists/Awards•2
Pricing strategy•0
Partners/Competitors•16
General
Jobs
Shortlists/Awards
Pricing strategy
Partners/Competitors
Details
Legal residence:UK
Types:Supplier
Funding agencies:EC, Other, Horizon 2020
Sectors:Health, Industry, Commerce & Services, Laboratory & Measurement
Nr. of employees:1001-5000
Status:Active
About
Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis. In July 2015, the two businesses joined forces to create Seqirus, now the second largest influenza vaccine company in the world. With extensive research and production expertise and manufacturing plants in the US, UK, Germany and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally. Seqirus has a workforce of over 2,000 employees, significant manufacturing capacity and a commercial presence in over 20 countries.
Awards
Top partners
Top competitors
Similar Companies
By Sectors and Organization Types
Country:
Brazil
Awards:
2
Jobs:
0
Country:
Armenia
Awards:
1
Jobs:
0
Country:
Kenya
Awards:
0
Jobs:
0
Country:
Palestine / West Bank & Gaza
Awards:
0
Jobs:
0